JPL Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$701 Buy
10
+5
+100% +$259 ﹤0.01% 1358
2026
Q1
$254 Buy
+5
New +$233 ﹤0.01% 1389
2025
Q4
Sell
-5
Closed -$130 737
2025
Q3
$130 Buy
+5
New +$139 ﹤0.01% 1162

Other funds holding MRNA

JPL Wealth Management's MRNA Position: Q2 2026 in Review

JPL Wealth Management increased its Moderna (MRNA) stake by 100% in Q2 2026, buying an estimated $259 and bringing the position to 10 shares worth $701. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

JPL Wealth Management first reported a position in MRNA in Q3 2025 and has held it in 3 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • JPL Wealth Management held 10 shares of Moderna worth $701 as of Q2 2026.
  • JPL Wealth Management bought 5 Moderna shares in Q2 2026, an estimated $259.
  • Moderna made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1358 holding.
  • JPL Wealth Management first reported a position in Moderna in Q3 2025 and has held it in 3 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.